NTI Urges Enhanced Focus on Biosecurity at Gathering of Synthetic Biology Experts
This week in
Singapore, NTI joins experts for the Seventh International Meeting on
(SB 7.0). SB 7.0 is a global gathering
of leading institutions focused on realizing societal benefits from synthetic
biology and discussing responsible practices. Beth Cameron, NTI’s Senior Director for Global
Biological Policy and Programs, was invited to participate in a security-centered dialogue during
this year’s event
that will focus on assessing and reducing risks posed by emerging technologies
and their applications.
urge gathered innovators to consider new and global strategies for mitigating
the risk of intentional misuse or accidental release associated with emerging
technologies in genome editing and synthetic biology, while maximizing the
potential for positive societal benefits. Cameron also will discuss NTI’s
perspectives on biosecurity, threat reduction, and global health security with
selected emerging leaders organized by the Johns Hopkins Center for Health
funding from the Open Philanthropy Project part of a new track focused on biosecurity and synthetic biology during SB 7.0 in coordination with
the BioBricks Foundation, SynBioBeta, & the National
University of Singapore.
about NTI’s biosecurity program here.
Sign up for our newsletter to get the latest on nuclear and biological threats.
Global Biosecurity Dialogue Convenes in Cape Town to Improve Biosecurity and Address Emerging Risks
NTI | bio convened experts from around the world from governments, industry, and civil society in Cape Town, South Africa to discuss emerging biological risks and offer actions to address them.
NTI | bio Attends a Cyberbiosecurity Workshop to Assess Opportunities and Challenges in India and Globally
NTI | bio’s Dr. Aparupa Sengupta joined a groundbreaking discussion on the nexus of cyber- and bio-security.